HF
CLLS

HRT Financial’s Cellectis CLLS Stock Holding History

HRT Financial’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,486
Closed -$353K – 2929
2021
Q1 		$353K Sell
17,486
-6,999
-29% -$173K ﹤0.01% 2019
2020
Q4 		$662K Buy
+24,485
New +$549K 0.01% 875

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

HRT Financial's CLLS Position: Q2 2021 in Review

HRT Financial sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 17,486 shares — an estimated $353K sold.

HRT Financial first reported a position in CLLS in Q4 2020 and held it in 2 quarters. The position peaked at $662K in Q4 2020. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.

  • HRT Financial reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
  • HRT Financial sold 17,486 Cellectis shares in Q2 2021, an estimated $353K.
  • HRT Financial first reported a position in Cellectis in Q4 2020 and held it in 2 quarters.
  • HRT Financial's Cellectis position peaked at $662K in Q4 2020.
  • 78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.

Based on HRT Financial's 13F filing for Q2 2021, filed 16 Aug 2021.